HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2023
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Oct. 16, 2023 -- HUTCHMED Limited today announces that new and updated clinical data from several ongoing studies of fruquintinib, in...